Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

ORABASE HCA

HYDROCORTISONE ACETATE

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ORABASE HCA is listed in Drugs@FDA under application 083205 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE Form and strength PASTE;TOPICAL - 0.5% Sponsor COLGATE Submission history Latest submission status date: 1990-09-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORABASE HCA is listed in Drugs@FDA under application 083205 (ANDA). Marketing status: Discontinued Active ingredient HYDROCORTISONE ACETATE Form and strength PASTE;TOPICAL - 0.5% Sponsor COLGATE Submission history Latest submission status date: 1990-09-11 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ORABASE HCA (HYDROCORTISONE ACETATE) | Drug Monograph | MedicHelpline